cilostazol

Known as: 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one, Cilostazole, cilostazol [Chemical/Ingredient] 
A quinolinone derivative and cellular phosphodiesterase inhibitor, more specific for phosphodiesterase III (PDE III). Although the exact mechanism of… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
OBJECTIVES We aimed to test whether cilostazol has beneficial effects in the real-world patients treated with intracoronary drug… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND The antiplatelet drug cilostazol is efficacious for prevention of stroke recurrence compared with placebo. We designed… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Cilostazol has been widely used to prevent peripheral vascular events, and its antiplatelet mechanisms may different… (More)
  • table I
  • table III
  • table II
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
OBJECTIVE Cilostazol, a selective inhibitor of PDE3, has a protective effect on endothelium after ischemic vascular damage… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
AIMS Patients with type 2 diabetes mellitus (T2DM) have reduced platelet inhibition compared with non-diabetics following P2Y(12… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Restenosis after implantation of coronary artery stents remains a significant clinical problem. We undertook a… (More)
  • table 2
  • table 1
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2000
Highly Cited
2000
PURPOSE We performed a randomized, double-blind, placebo-controlled, multicenter trial to evaluate the relative efficacy and… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Cilostazol, an antiplatelet drug that increases the cyclic adenosine monophosphate (AMP) levels in platelets via inhibition of… (More)
  • table 1
  • table 2
  • figure 1
  • table 4
  • table 3
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND Cilostazol is a new phosphodiesterase inhibitor that suppresses platelet aggregation and also acts as a direct… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
1985
Highly Cited
1985
A new antithrombotic drug, cilostazol (6-[4-(1-cyclohexyl-1 H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone, OPC-13013) was… (More)
Is this relevant?